SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+71.8%
5Y CAGR+51.1%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+71.8%/yr
Quarterly compound
5Y CAGR
+51.1%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
7.9x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.87% |
| Q3 2025 | 6.20% |
| Q2 2025 | -20.78% |
| Q1 2025 | -13.03% |
| Q4 2024 | 3.19% |
| Q3 2024 | 6.21% |
| Q2 2024 | 13.08% |
| Q1 2024 | -8.51% |
| Q4 2023 | 2.54% |
| Q3 2023 | 2.42% |
| Q2 2023 | 14.44% |
| Q1 2023 | -4.90% |
| Q4 2022 | 2.34% |
| Q3 2022 | 4.87% |
| Q2 2022 | 23.17% |
| Q1 2022 | -11.63% |
| Q4 2021 | 1.67% |
| Q3 2021 | 0.49% |
| Q2 2021 | 22.86% |
| Q1 2021 | -11.53% |
| Q4 2020 | 1.51% |
| Q3 2020 | 14.09% |
| Q2 2020 | 3.40% |
| Q1 2020 | -8.80% |
| Q4 2019 | 1.70% |
| Q3 2019 | -1.03% |
| Q2 2019 | 23.00% |
| Q1 2019 | -13.71% |
| Q4 2018 | 7.62% |
| Q3 2018 | 1.22% |
| Q2 2018 | 7.04% |
| Q1 2018 | 4.99% |
| Q4 2017 | -4.59% |
| Q3 2017 | 5.33% |
| Q2 2017 | -0.79% |
| Q1 2017 | -19.36% |
| Q4 2016 | -11.85% |
| Q3 2016 | 0.46% |
| Q2 2016 | -0.02% |
| Q1 2016 | 20.91% |